Innovation
expressPIK
1st RNA-based test for targeted treatment eligibility. expressPIK makes the right choice of treatment a reality.
expressPIK
1st RNA-based test for targeted treatment eligibility. expressPIK makes the right choice of treatment a reality.
Our platform
1st RNA & AI-based technology for targeted treatment eligibility.
than with DNA testing
Prognostic AI Algorithm
Many cancers, many mutations
Patients are being misguided for Treatment.
At expressTEC we are developing the first RNA and AI based technology to accurately select patients for targeted therapies. Our 1st product, expressPIK, precisely identifies the most common mutations found in breast tumours, and is a proof of concept for our larger vision of a platform to test many mutations in all cancer types.
Accurate, Easy and Fast to implement.
Our mission is to empower healthcare professionals with fast and reliable tools that identify the most suitable patients for treatment, ensuring optimal therapeutic efficacy while minimising side effects.
Winner of the 'Altice International Innovation Award 2023'
This technology allows "signing the personalisation of a therapy". The recognition, in turn, represents an "opportunity to learn to develop the business side and the transfer of technology, something that scientists are little used to".
We have 30+ years of experience in Cancer Research.
Both co-founders are experienced researchers in human and cancer genetics, particularly in
breast cancer genomics. Both have a successful past in securing research funding and leading
teams.
Our Team
Our team boasts a remarkable blend of diverse talents, seamlessly integrating scientific expertise with business acumen. We foster a dynamic, multidimensional approach that fuels innovation and drives transformative results.
PhD, EMBA, Co-founder and CEO
PhD, Co-founder and CTO
MBA, Chief Marketing Officer
MSc, Research Scientist
About expressTEC
The project has garnered recognition and validation from experts. These endorsements highlight the project's quality and positive impact on the professional community, solidifying its credibility and success.
Support us and start to promote this idea.
We want to contribute to impacting the lives of breast cancer patients worldwide.
Latest News
Stay up to date with the main news about the project expressTEC
expressTEC proudly emerged as the winner of the Elétrico Pitch 2024, an innovative event that transformed Portugal Tech Week with
The start-up "expressTEC," led by Ana Teresa Maia and Joana Xavier, is the winner of the ninth edition of the
The start-up expressTEC, led by Ana Teresa Maia and Joana Xavier, is the winner of the Altice International Innovation Award
A team of researchers from the Health Technologies and Services Research Centre (CINTESIS), representing the University of Algarve, has just
ExpressTEC, a spin-off incubated at the University of Algarve, was one of seven Portuguese technology-based companies led by women selected
If you're keen to collaborate with us...
expressTEC is currently looking for partner institutions (Hospitals and Clinical labs) to conduct Clinical Trials for the products in its pipeline. Please contact us if your institution wants to know more about this opportunity.
